Oncology leads personalized medicine with targeted therapies, genomic profiling, and immunotherapy. Cardiovascular and rare disease care also benefit.
FDA AND REGULATORY FRAMEWORK
In 2024, 38% of FDA-approved new drugs were personalized. Evolving regulations ensure safety while supporting precision therapy innovation.
DIGITAL HEALTH AND REMOTE MONITORING
Mobile apps, wearables, and telehealth enable real-time monitoring, data collection, and personalized interventions for improved patient care.
FUTURE TRAJECTORY
Genomics, AI, and data integration will make precision medicine standard care. Personalized treatments will expand across medical fields for better outcomes.